Dishman Carbogen Amcis Limited has informed the Exchange about General Updates
DCAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dishman Carbogen Amcis Limited announced that its wholly-owned subsidiary, Carbogen Amcis B.V. in the Netherlands, has received a Certificate of GMP (Good Manufacturing Practice) Compliance for its Veenendaal site. The certificate was issued by the Dutch Health and Youth Care Inspectorate (IGJ), the competent regulatory authority in the Netherlands. GMP compliance is a key regulatory requirement that allows the facility to manufacture and supply pharmaceutical products for commercial use. This certification strengthens the company's manufacturing credentials in the European market and supports its contract development and manufacturing (CDMO) business.
Positive for shareholders — the GMP certification enables the Veenendaal site to undertake commercial pharmaceutical manufacturing, potentially boosting revenues from European clients and reinforcing the company's standing as a compliant global CDMO player.